Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With their fake covid tests from Dablood lol. Of all the places they could of acquired tests they had to go with the fake ones. But hey those were cheapest. Why hasn't Wellgistics sued them? Maybe the money was fake too?
So how will this help PRED?
Looks like it could be a great day. bid .11 ask .13
When will PRED see .70 again?
I agree enough fluff PR's need the real deal. Positive mouse studies.
I want to see the COVID mouse studies completed, complete with dancing mice.
That's all the otc is is hopes and dreams.
DANG it I thought we were going up today too? 500% would of been a nice day. Oh well there's always 5000% right?
Let's not pick and choose. Here's the rest:
According to the American Cancer Society, nearly 1.5 million new cases of cancer are diagnosed in the U.S. each year. While particularly effective against Multidrug Resistant Cancer, we believe Adva-27a can potentially treat all cancer types, particularly those in which Topoisomerase II has been amplified. We believe that upon successful completion of Phase I Clinical Trials we may receive one or more offers from large pharmaceutical companies to buyout or license our drug. However, there are no assurances that our Phase I Trials will be successful, or if successful, that any pharmaceutical companies will make an acceptable offer to us. In the event we do not consummate such a transaction, we will require significant capital in order to manufacture and market our new drug on our own. The following, Figure 3, is a space-filling molecular model of our Adva-27a.
Show me where it says they started the trials for Pancreatic cancer at the Jewish hospital in Montreal.
Post the number of the post please. From the original poster who said that the received the drugs. OH BTW like I said I hope we get the up tier listing on 4-1-21. OR tomorrow ? But I like 4-1 for the shorts.
HAHA yes it is old news SO WHY AREN'T THEY SELLING and NO I have ALL THE shares I need. BAD CALL
Where are they with these?
Generic Pharmaceuticals Operations
In 2016, our Canadian wholly owned subsidiary, Sunshine Biopharma Canada Inc. (“Sunshine Canada”), signed Licensing Agreements with a major pharmaceutical company for four prescription generic drugs for the treatment of Breast Cancer, Prostate Cancer and Enlarged Prostate. We have since been working towards commencement of marketing of these pharmaceutical products under our own, Sunshine Biopharma, label. These four generic products are as follows:
? Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer;
? Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer;
? Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer;
? Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)
Sunshine Canada is currently in the process of securing a Drug Identification Number (“DIN”) for each of these products from Health Canada. We are also required to obtain a Drug Establishment License (“DEL”) from Health Canada. Upon receipt of the DEL and DIN’s, we will be able to accept orders for our own label SBI-Anastrozole, SBI-Letrozole, SBI-Bicalutamide and SBI-Finasteride. We cannot estimate the timing for our obtaining either the DIN’s or the DEL due to variables involved that are out of our control. Figure 4 shows our 30-Pill blister pack of Anastrozole.
ese and other preclinical data have been published in ANTICANCER RESEARCH, a peer-reviewed International Journal of Cancer Research and Treatment. The publication which is entitled “Adva-27a, a Novel Podophyllotoxin Derivative Found to Be Effective Against Multidrug Resistant Human Cancer Cells” [ANTICANCER RESEARCH 32: 4423-4432 (2012)] is available on our website at www.sunshinebiopharma.com.
We have been delayed in our clinical development program due to lack of funding. Our fund raising efforts are continuing and as soon as adequate financing is in place we will continue our clinical development program of Adva-27a by conducting the following next sequence of steps:
? GMP Manufacturing of 2 kilogram for use in IND-Enabling Studies and Phase I Clinical Trials I believe this step is done?
? IND-Enabling Studies
? Regulatory Filing (Fast-Track Status Anticipated)
? Phase I Clinical Trials (Pancreatic Cancer Indication)
Adva-27a’s initial indication will be Pancreatic Cancer for which there are currently little or no treatment options available. We are planning to conduct our clinical trials at McGill University’s Jewish General Hospital in Montreal, Canada. All aspects of the clinical trials in Canada will employ FDA standards at all levels.
The email said they received the drug. Didn't say they started trials. FROM what I recall.
need more green lol Need some lively mice dancing around too!
Wouldn't it be IRONIC we get UPLISTED on APRIL FOOLS day?
When's the CAVEAT EMPTOR going to be REMOVED? Will that take another year like getting off the grey's?
With a PPP loan yes!
They have BRAD, Merle and Rich!!! Will they go down with the ship?
I doubt any institutions will touch a stock under $5.
I don't think a tier change will make that much difference if they went up 2 tiers that would make a bigger difference obviously. It's probably going to be more news related than just a tier change. What comes out of the mouse studies that's going to be big catalyst.
UWHR went up a little.
UP 10% man it's going to $1.00
My buddy bought 900k @.966 today that's half the volume alone!
I think so it's funny I was always expecting we get it on around April fools day!
We need it to stabilize and uplisting. then positive mouse covid news.
WE NEED NEWS SOON! I don't know why they say this needs a year? If the mouse studies are almost done why will it take a year? For the pills to get FDA approval?
Birdman pumping must be working up .035 wow. LOL YUGE volly 760
That's awesome news alone. Thanks!!!
Yeah this whole Covid is out of control. Putting people out of work/business not allowing people to travel. Borders shut down. Cities shut down. Countries shutdown. Now they say the monkeys in India are getting it.
Did they sign a consent form?
First great apes at U.S. zoo receive COVID-19 vaccine made for animals
Orangutans and bonobos at the San Diego Zoo have received a coronavirus vaccine, Nat Geo has learned, after some zoo gorillas tested positive in January.
Or crash and go lower on a no news week again? Can we get back to .13 sheesh. MM games.
Next time someone calls Camille ask about when and where are the generics coming on line? Been years since they said they were going to sell them.
That was the cancer drug they bought from a Chinese company. Don't know who is going to make they're Covid pill if it ever gets that far???
Almost until it's not. Another 4 more days of MM games. Then maybe news next week? If not we drift lower until it happens.
A new alias and comes right to sbfm lmfao.
You mean 3.5 million?
REVENEWS! OR very positive test results. Anyone have any idea what the supplements will bring in per year?
But where were the millions promised in Covid testing? Did they even run and at all?
How long does a mouse study take? I'd say from the PR's and the patents they know the results of this study.
ONTREAL, QC / ACCESSWIRE / October 17, 2019 / Sunshine Biopharma, Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive forms of cancer, today announced that it has initiated studies of Adva-27a in xenograft mice. In these studies, specifically engineered mice which have developed tumors following injection with patient derived cancer cells are treated with Adva-27a to assess the ability of the drug to shrink the tumors. Among the different types of patient derived cancer types being studied are Pancreatic Cancer, Breast Cancer, Small-Cell Lung Cancer and Uterine Sarcoma.
About Adva-27a
Adva-27a is Sunshine Biopharma's proprietary anticancer compound. In vitro tests conducted on Adva-27a have demonstrated the drug's effectiveness at destroying Multidrug Resistant Cancer Cells including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells, and Uterine Sarcoma cells. Clinical trials for Pancreatic Cancer indication are planned to be conducted at McGill University's Jewish General Hospital in Montreal, Canada. Sunshine Biopharma is owner of all patents and intellectual property pertaining to Adva-27a.
He was also a shorter? That SEC complaint was for P&D.